Earnings mechanism
Workflow and operating-model redesign change how the company works. The available evidence most strongly associates this mechanism with EBIT impact during the hold period.
What institutional function should decide where AI capital goes, how much authority machines are permitted to hold, and which capabilities should compound across a private-equity portfolio?
The missing layer is not another AI centre of excellence. It is an allocation function.
Private equity has largely settled the question of AI adoption and has not settled the question of AI realisation. Sponsors increasingly have models, pilots, vendors, operating partners, and portfolio AI strategies. What they still lack is a disciplined institutional mechanism for allocating AI capital, governing delegated machine authority, proving realised value, and carrying what works from one holding to the next.
Musewoods Press · Strategy
AI activity is no longer scarce. The scarce institutional capability is deciding where AI capital should go, what machines are permitted to change, what evidence proves the investment worked, and which capabilities should survive long enough to compound across the portfolio.
The design borrows an institutional principle from Berkshire Hathaway rather than an investment model: centralise the scarce judgment, decentralise operations, protect against permanent loss, learn from postmortems, and redeploy what works.
Enter the argument00
Executive frame
The AI Program Office is the sponsor-level institution that underwrites, allocates, governs, proves, transfers, and compounds.
The paper can be understood as five connected claims.
Sponsors are funding pilots, appointing AI leaders, negotiating model access, and encouraging portfolio companies to move. Activity is real; realised enterprise value remains uneven.
The sponsor has mature machinery for allocating equity capital and far less discipline for deciding which AI opportunities deserve investment, at what scale, against which economic thesis, and with which kill criteria.
A system that can change price, release code, approve a transaction, or contact a customer is exercising delegated authority. Permission must therefore be allocated, evidenced, bounded, observable, and revocable.
The first deployment is valuable locally; the sponsor-level advantage appears only when architecture, evidence, controls, methods, and operating knowledge reduce the cost and risk of subsequent deployments.
The office earns its mandate by remembering what was underwritten, what was actually realised, what failed, what transferred, and which forms of authority proved safe enough to expand.
The AI Program Office is the sponsor's institutional mechanism for allocating AI capital, governing delegated machine authority, transferring proven capability across portfolio companies, and compounding AI-enabled enterprise value across successive holdings.
01
The constraint
The absence of an allocation function turns AI strategy into distributed enthusiasm, vendor influence, and uneven management attention.
A private equity firm has a highly developed apparatus for deciding where equity capital should go. Investment committees, underwriting standards, hurdle rates, hold-period models, downside cases, and exit theses exist because capital is scarce and mistakes compound. AI capital is being deployed with far less institutional discipline. Sponsors may fund multiple pilots, appoint AI leaders, negotiate portfolio-wide model agreements, and ask each company to write an AI strategy, yet the decision about which opportunity deserves material capital is often still made informally through operating-partner conviction, management enthusiasm, vendor relationships, and local urgency.
The asymmetry is difficult to defend. The same institution that would not commit two million dollars of equity without a written investment thesis can commit comparable AI spend across a portfolio without an explicit baseline, economic mechanism, authority model, attribution method, transfer thesis, or pre-agreed condition for stopping. The problem is not lack of activity. It is lack of allocation discipline.
Capital allocation without an authority model produces fast adoption and unbounded downside. Authority governance without capital allocation produces a compliance function that slows everything and improves nothing.
The AI Program Office exists to hold both problems at once. It treats AI capital as an investment portfolio rather than a technology budget, and it treats machine authority as a bounded institutional resource rather than as a capability implicitly granted when a system reaches production. The sponsor-level function is therefore neither a central implementation team nor a detached governance office. It is the place where economic judgment and delegated authority are made explicit before consequential work moves.
02
Evidence
The evidence supports building an allocation function, but it does not support pretending that one fixed AI playbook explains every source of value.
The broad enterprise picture is consistent. AI activity is widespread, innovation and efficiency are common objectives, and the earnings consequence remains concentrated. Across McKinsey's survey waves, fundamental workflow redesign has the strongest association with whether organisations report EBIT impact, yet only about a fifth of adopters had fundamentally redesigned a workflow at the time of measurement. The scarce input is therefore not simply model access. It is the willingness and institutional capacity to change how work is actually done.
The private-equity evidence points in the same direction. Boston Consulting Group observed in January 2026 that PE leaders believed strongly in AI's value-creation potential and were investing in technology and talent, while the sector's realised impact remained modest and few firms could demonstrate meaningful returns across many portfolio companies. BCG's distinction between deploy, reshape, and invent is useful because it separates licence distribution from operating-model redesign and from AI embedded directly into the product or business model.
Workflow and operating-model redesign change how the company works. The available evidence most strongly associates this mechanism with EBIT impact during the hold period.
Embedding AI into products, services, or new businesses changes what the company sells. The available PE-specific evidence associates this mechanism with the larger valuation step.
The valuation inflection in McKinsey's 471-company PE-backed sample did not appear between opportunistic adoption and operating-model enhancement. It appeared when AI changed what the company sold. Set beside the workflow evidence, that produces a two-mechanism allocation view: operating-model work primarily buys earnings; product and business-model work may buy the exit multiple.
What the evidence will and will not carry
01
The 471-company study spans thirty countries and thirty-one industries, but only twenty-one companies sit at the highest AI maturity level.
The association between higher AI maturity and higher revenue multiples is real in the sample. The direction of causation is not recoverable, especially because younger, software-weighted, AI-native businesses may both describe themselves differently and trade differently.
What claim survives the selection effect?
02
Agent deployment remains in the low single digits across most business functions.
The authority problem is strategically important before it is broadly measured. That is a reason to build the architecture early, not a reason to overstate current autonomous adoption.
How much can any portfolio credibly claim about autonomous execution today?
03
The widely circulated claim that ninety-five percent of AI pilots fail derives from a preliminary, non-peer-reviewed report with publicly contested methodology.
The office needs a stronger evidentiary standard than the market's rhetoric. A memorable statistic is not a substitute for a source that can carry the claim being made.
What should an investment memorandum refuse to repeat?
TAKEAWAY ON EVIDENCE
The evidence is strong enough to justify building an allocation function and too thin to justify a fixed playbook. That asymmetry is itself an argument for an office whose primary output is evidence.
03
Competitive reality
Portfolio compounding is now consensus. Authority allocation, evidentiary discipline, transfer option pricing, and structural independence are not.
The market no longer permits a claim that private equity lacks centralised AI capability. EQT's Motherbrain spans the investment lifecycle and has extended into portfolio-facing advisory work. KKR's Capstone model integrates operating capability with deal teams. Vista embeds engineers, operators, and AI specialists inside portfolio businesses. Google Cloud has reached portfolio-wide arrangements with multiple sponsors, and Blackstone and Hellman & Friedman formed Ode with Anthropic in 2026. EY reporting indicates that roughly four in five US private-equity firms have appointed a chief AI officer.
The portfolio-transfer argument is equally public. BCG recommends piloting repeatable playbooks and translating them across holdings. McKinsey describes the PE firm's role as expanding from asset selection toward repeatable AI-enabled initiatives that can create value across the fund and become reusable in future investments. Portfolio compounding is therefore not the discovery. It is the starting assumption.
Each common construct solves a real problem and fails as the sponsor's allocation function.
Expertise and standards
Holds no capital and therefore no leverage over which initiatives actually receive investment.
Implementation and change
Learning is bounded to the project or company and often disappears when the engagement ends.
Common capability and cost efficiency
Optimises for what is easy to standardise rather than what carries the greatest enterprise value.
Expertise and execution capacity
Accumulated judgment leaves when the team does, and incentives may favour implementation volume over stopping.
Four commitments remain structurally under-supplied.
Decide what machines may change, on whose identity they act, what evidence supports autonomy, and what revokes permission.
Capture baselines before deployment, record attribution methods, and compare realised outcomes with the thesis that justified the spend.
The expected reuse count should be named before the first deployment and tested after the first year.
The party deciding whether a programme should expand, stop, or change vendors should not earn more when implementation volume increases.
04
The thesis
Its product is an allocation decision supported by evidence. Its asset is the accumulating record of which decisions were right.
The AI Program Office is the sponsor's institutional mechanism for allocating AI capital, governing delegated machine authority, transferring proven capability, and compounding AI-enabled enterprise value across successive holdings.
Maximum risk-adjusted enterprise value per unit of AI capital and per unit of machine authority.
The office underwrites opportunities, allocates scarce shared capability, defines authority boundaries, measures realised economics, captures reusable assets, and transfers what works. It does not optimise for number of pilots, licences, agents, or initiatives in flight.
Not a centre of excellence. Not an internal consultancy. Not a central implementation factory.
The operating companies remain responsible for their business problems, workflows, management decisions, implementation choices, adoption, and P&L outcomes. The office centralises the judgment and the non-negotiable boundaries that benefit from portfolio scale while leaving operating responsibility where the context actually lives.
05
Institutional architecture
The useful translation is a small centre governing a large collection of autonomous businesses through allocation discipline, hard boundaries, postmortems, resilience, and redeployment.
Berkshire Hathaway is not a model for private equity. Its ownership horizon, capital structure, and acquisition philosophy differ materially from those of a buyout fund. The useful borrowing is institutional: centralise the scarce judgment, decentralise operations, preserve hard controls, learn from mistakes, and redeploy what one business generates into another.
Six Berkshire translations
The analogy is valuable where it disciplines allocation and dangerous where it hides the differences between permanent ownership and a finite hold.
Principle
01
A fund-level office that tries to run AI inside every portfolio company becomes slow and context-poor; a fund that delegates everything gets incompatible systems and no institutional learning.
Operating questionWhat belongs at sponsor level, and what must stay inside the operating company?
The office should establish investment doctrine, underwrite material opportunities, allocate scarce shared capability, set architecture and authority boundaries, maintain a common evidence standard, codify reusable assets, and measure portfolio economics. The portfolio company should define the business problem, own the operating outcome, execute the change, adapt to local systems, produce evidence, and deliver the P&L result. Centralise judgment and non-negotiable boundaries; decentralise operating decisions and accountability.
THE ABCs OF AI DECAY
Arrogance assumes model capability implies production reliability. Bureaucracy turns governance into committees and approval queues rather than executable boundaries. Complacency mistakes procurement or a published AI strategy for transformation. The office needs institutional habits that push against all three.
06
Operating model
The office manages five forms of capital through four institutional systems and one explicit authority architecture.
Budget is only one scarce resource.
Investment budget
Where does the next dollar create the greatest risk-adjusted value?
Architects · engineers · infrastructure
Where should scarce implementation capability be deployed?
Proprietary information and access
Which data assets warrant integration, protection, or productisation?
Executive attention
Which initiatives deserve CEO, board, and operating-partner attention?
Permission for machines to act
Where can autonomy safely expand, and where must it remain constrained?
Treating authority as capital has a practical consequence: the office maintains a register of how much machine authority is outstanding across the portfolio, which systems hold it, what evidence earned it, and what conditions would cause it to be withdrawn. Compute can be purchased. Trusted authority has to be earned and maintained.
Four institutional systems
Each system exists because the previous one cannot safely answer the next question by itself.
System
01
A rapid assessment is an entry mechanism; the durable output is an AI Investment Memorandum.
Operating questionWhat must be true before the sponsor should invest?
Each memorandum states the business problem and baseline economics, the proposed intervention, expected operating change, capital required, implementation risk, authority level requested, expected economic outcome, evidence required before scaling, transferability to other companies, and the conditions under which the initiative should be terminated. Kill criteria are written before capital is committed because criteria written after a programme has a champion are not credible kill criteria.
Every material capability carries an explicit delegation boundary.
What may the system decide or change?
On whose authority does it act?
What information must support the action?
When may it act autonomously?
What requires a human decision?
What evidence must be retained?
Can the action be undone?
Who owns the resulting outcome?
Runtime architecture
Decision, enforcement, evidence, competency, and accountable action should remain distinguishable.
In the 451 architecture, Pola is the policy decision point and decides. The Governor is the policy enforcement point and enforces while holding no write path of its own. Actra is the governed event stream that preserves accountable action history. Hubli supplies the competency and promotion surface and holds no decision or enforcement power. The separation matters because a governance layer that can also act is not a governance layer.
07
Economic architecture
Realised value, transfer economics, authority exposure, and strategic optionality have to be visible in one operating view.
A portfolio-wide ledger compares AI investment hypotheses with economic reality.
Cash, people, infrastructure, and management attention
Expected annual or exit-period economic contribution
Verified economic benefit achieved
Duration from commitment to measurable result
Quality of the supporting evidence
Downside created or mitigated
Applicability elsewhere in the portfolio
Cost of the next deployment
Consequence of autonomous action
New products, markets, data, or business models enabled
Every portfolio company will generate more plausible AI opportunities than the fund can economically pursue, so scarcity should be made explicit rather than diffused. Initiatives compete on enterprise-value potential, probability of success, time to value, strategic importance, transferability, and risk. The ranking should be visible rather than negotiated privately, and the resulting allocation should be asymmetric by design.
Some companies should receive materially more AI capital than others. Some need defensive modernisation only. A smaller number warrant operating-model transformation, and fewer still justify AI-native product development or business creation. Equal-budget allocation and a rule that every company needs an AI strategy are symptoms of a sponsor that has not created an allocation function.
Let the first deployment cost C and return annual benefit B. Let r be the share of first-deployment cost eliminated on subsequent deployments through captured architecture and operating knowledge, and let k be the share of the original benefit a subsequent deployment achieves. With C at $600,000, B at $1.5 million, r at 0.71, and k at 0.5, subsequent deployments cost $175,000 and return $750,000 annually.
| Deployments | Portfolio cost | Annual benefit | Benefit to cost | Capital saved versus building fresh |
|---|---|---|---|---|
| 1 | $600,000 | $1,500,000 | 2.50 | 0 |
| 2 | $775,000 | $2,250,000 | 2.90 | $425,000 |
| 3 | $950,000 | $3,000,000 | 3.16 | $850,000 |
| 5 | $1,300,000 | $4,500,000 | 3.46 | $1,700,000 |
| 8 | $1,825,000 | $6,750,000 | 3.70 | $2,975,000 |
Two sensitivities determine whether the compounder thesis holds. Reuse capture drives marginal economics directly, and realised reuse count determines how much of the claimed portfolio value exists at all. Under the illustrative assumptions above, a transfer needs only $437,500 of annual benefit to clear a 2.5x first-year hurdle. The binding constraint is therefore not whether a successful transfer can pay. It is whether the organisation actually transfers.
The first deployment should consequently be underwritten as the purchase of a capability plus an option on a named set of subsequent deployments at reduced marginal cost. The expected reuse count belongs in the original memorandum, should be associated with specific candidate companies, and should be tested at the twelve-month review. An option nobody has priced is an option nobody is accountable for exercising.
Redesign workflows and operating models when the hold period and business condition favour EBITDA, margin, productivity, or operating improvement.
Embed AI into products, services, or new businesses when the company has enough time and strategic position for the market to value a changed proposition.
ALLOCATION RULE
Productivity tooling that changes neither operating economics nor what the company sells is a hygiene cost. Procure it; do not pretend it is an investment thesis.
08
Deployment
The first year should prove that the office can find value, stop weak investments, codify what works, and make deployment N+1 measurably better because deployment N occurred.
Days 0–60
Rapid underwriting runs across selected companies, the ledger is stood up, and existing initiatives, vendor commitments, capabilities, risks, and economic hypotheses are inventoried. The objective is three answers: where value is available, where capital is being wasted, and where AI could threaten a current underwriting assumption.
Days 60–120
The office establishes the investment memorandum, authority classification, economic scorecard, kill criteria, and portfolio review cadence. A small number of initiatives are selected to generate evidence rather than maximise activity.
Months 4–8
Selected initiatives execute, realised economics are measured against the memorandum, and reusable architecture, implementation patterns, evaluation assets, and governance mechanisms are captured. Candidate compounders must become visible here.
Months 7–12
The office deliberately moves proven capability across holdings and measures whether deployment N+1 is cheaper, faster, and more reliable because deployment N occurred. This is where the office earns or loses its sponsor mandate.
Keep the scorecard short enough that it can change allocation decisions.
Verified value created per unit of AI capital, annualised EBITDA or revenue impact, and enterprise-value contribution.
Median time from underwriting to verified value, share killed before major commitment, and share meeting the original economic thesis.
Reuse count per codified capability, marginal cost reduction, time reduction, and number of validated compounders.
Share of material systems carrying explicit authority envelopes, evidence completeness, and material incidents measured against authority outstanding rather than system count.
Strategy and allocation
Connects investment theses to operating economics
Defines reusable technical foundations and interoperability
Defines authority, evidence, policy, and assurance
Connects the office to CEOs, operating partners, and implementation teams
Specialist implementation capacity should come from portfolio teams, external partners, or a governed engineering bench. The office should resist becoming a permanent delivery organisation because its leverage comes from judgment, architecture, accumulated knowledge, and reuse; a delivery organisation's incentives naturally pull toward volume.
A mature office affects the full investment lifecycle. Underwriting improves because the fund develops a proprietary view of which businesses are genuinely advantaged or threatened by AI. Time from acquisition to economic intervention shortens because common architecture, evidence standards, and operating patterns already exist. Portfolio economics improve because shared learning lowers the marginal cost and execution risk of transformation.
Exits can improve because the sponsor can present evidence of AI-enabled operating change and proprietary capability rather than a generic claim that a company is AI-enabled. Management teams gain access to capabilities they could rarely justify alone, which strengthens the acquisition proposition. Limited partners gain evidence that the fund has developed a repeatable operating capability rather than relying only on deal selection and leverage. The last of these is also the simplest to test: a fund that cannot show the ledger has not built the capability.
09
Differentiation
Portfolio compounding, central capability, investment-thesis alignment, and reusable playbooks are already in the market and are not claimed as novel.
Beginning with evidence rather than a transformation hypothesis is standard practice among credible entrants. Connecting AI to the investment thesis is the explicit position of major strategy and private-equity advisory firms. Centralising fund-level capability and transferring playbooks between holdings is published advice and installed practice. Well-capitalised implementation ventures will also build reusable intellectual capital faster than a small advisory organisation can. None of those positions is a defensible differentiation basis.
What survives contact with the landscape
Maintain an authority register, issue explicit envelopes, separate decision from enforcement, and widen permission only against accumulated competency evidence.
Hold no revenue relationship with a model provider, cloud provider, or implementation venture when advising the sponsor on whether to expand, replace, redesign, or stop.
Capture baselines before deployment, record attribution methods, and distinguish what was measured from what was reported.
Name expected reuse count, assign candidate companies, and test the option at review because the portfolio return depends on realised transfer rather than on rhetoric about reuse.
POSITIONING VERDICT
Proceed with these four commitments as the differentiation basis. Stop any claim that portfolio compounding itself is novel; that belongs to the published market record.
Constraints the model must survive
01
Operating knowledge, benchmarks, pricing capability, and data models may carry confidentiality, co-investor, competition, and antitrust obligations.
The office needs counsel-approved transfer classes. Generic architecture, methods, evaluation patterns, and governance artefacts may travel more freely than commercially sensitive operating knowledge, pricing, customer information, or data.
What may travel safely between holdings?
02
The deployed instance belongs to the company that will eventually be sold.
Codification cannot be a post-project courtesy. Fund-level artefacts should be produced as a condition of funding and designed to survive the sale of the operating company.
What must the sponsor capture before exit?
03
The strongest PE-specific dataset is associative, selected, and small at the highest maturity level.
The ledger is partly a value-management system and partly a mechanism for generating the causal evidence the field does not yet possess. The office should make uncertainty visible rather than hide it behind industry confidence.
What should the office do with uncertainty?
04
Many sponsors have already appointed chief AI officers and may reasonably decide that the function belongs inside.
If structural independence, allocation discipline, and evidence are not valued as distinct capabilities, the correct response is not to reposition as staff augmentation. It is to decline.
When should an external office decline the engagement?
10
Falsification
The model is useful only if it can fail.
Five conditions would materially weaken or overturn the thesis.
If realised reuse count across codified capabilities stays below two after twelve months of deliberate transfer effort, portfolio compounding is arithmetic without a referent.
If sponsors treat authority envelopes as compliance paperwork rather than an allocation instrument, the differentiated governance layer collapses into documentation.
If stronger controlled studies show that AI-native founding characteristics rather than purchasable AI capability explain the valuation steps, the allocation rule reduces to the earnings mechanism alone.
If the large implementation providers create credible independent mechanisms for allocating and constraining machine authority, this position loses one of its central structural advantages.
If the model depends entirely on sponsor-level budget, its economics and organisational design change materially.
Berkshire's advantage was never that headquarters ran each operating company better than its own management. The advantage came from disciplined selection, rational allocation, deep delegation, protection against permanent loss, learning from mistakes, resource redeployment, and the ability to let advantages generated in one business create opportunity elsewhere.
Private equity has a parallel opportunity, but the opportunity is no longer the generic idea of portfolio AI. What remains structurally useful is the harder half: an allocation function that treats machine authority as capital, holds realised value to an evidentiary standard, prices transfer option value into the original underwriting, and remains independent of the parties selling the implementation.
Underwrite before investing. Allocate rather than distribute. Delegate within enforceable boundaries. Measure intrinsic value rather than activity. Transfer what works within the limits counsel permits. Learn from what does not. Protect against permanent loss. Compound only what survives the exit.
A conventional AI programme asks where AI can be used. A transformation programme asks where AI can improve this business. The Compounding AI Program Office asks where AI capital and machine authority should be allocated today so that the value of this company rises while the capability of the portfolio rises with it.
Appendix
Every material empirical claim should remain attached to what supports it and what it cannot prove.
| # | Claim | Source and standing |
|---|---|---|
| 1 | 39 percent of organisations report any enterprise EBIT impact from AI; roughly 6 percent qualify as AI high performers | McKinsey State of AI global survey 2026, 1,719 respondents. Primary source. One secondary report renders the first figure as 37 percent; the primary is used here. |
| 2 | Fundamental workflow redesign has the strongest association with EBIT impact; about 21 percent of adopters had attempted it | McKinsey State of AI, March 2025 wave, tested against roughly 25 organisational attributes. Association, measured across a general enterprise sample rather than a PE sample. |
| 3 | Few PE firms could show meaningful AI returns across portfolio companies in 2025; deploy, reshape, invent framework | Emerson, O'Niell, and Kapadia, BCG, 23 January 2026. Practitioner observation supported by BCG's transformation base rather than a published instrument. |
| 4 | 471 PE-backed companies classified into four AI capability levels | Pulido, Yegoryan, Bleys, and Haas, McKinsey, 23 June 2026. |
| 5 | Level four median revenue multiple of 31x; broad adopters roughly 130 percent above opportunistic; revenue per employee $180,000 at level four against $118,000 at level three | Same source. Sample restricted to 2023-onward deals, revenue $1M to $250M, multiples 5x to 300x, 30 countries, 31 industries, median founding year 2015, with 21 companies at level four. Association, not causation. |
| 6 | Level one and level two median multiples are 13x and 14x, with the inflection at level three | Same source. This is the basis of the two-mechanism allocation rule. |
| 7 | Agent deployment remains in the low single digits across most business functions | Stanford HAI AI Index 2026. Constrains claims about autonomous execution at portfolio scale. |
| 8 | Roughly four in five US private-equity firms have appointed a chief AI officer | Attributed to EY and reached through secondary reporting. Directional pending the primary instrument. |
| 9 | Landscape positions: EQT Motherbrain and Motherbrain Labs, KKR Capstone, Vista's embedded model, Google Cloud portfolio agreements, and the Ode venture | Company disclosures and trade reporting, 2024 to 2026. |
| 10 | Compounder parameters: $600,000 first deployment, $1.5 million annual benefit, 0.71 reuse capture, 0.5 benefit ratio | Assumptions, not findings. The model exposes sensitivity so sponsors can substitute their own parameters. |
| 11 | The claim that ninety-five percent of AI pilots fail | Not used. It derives from a preliminary, non-peer-reviewed report with publicly contested methodology. |
Sources
Sources supporting the empirical and institutional argument.
Buffett, W. E. · 2015 · Special letter in Berkshire Hathaway Inc. 2014 annual report
Edlich, A., Llewellyn, C., Croke, C., Schneider, R., & Teichner, W. · McKinsey & Company · 2026
Emerson, G., O'Niell, C., & Kapadia, T. · Boston Consulting Group · 23 January 2026
McKinsey & Company · QuantumBlack · 2025
McKinsey & Company · QuantumBlack · 2026
Pulido, A., Yegoryan, H., Bleys, J., & Haas, S. · McKinsey & Company · 23 June 2026
Reddy, S. · SSRN · 2026
Reddy, S. · SSRN · 2026
Reddy, S. · SSRN · 2026
Stanford Institute for Human-Centered Artificial Intelligence · Stanford University · 2026
Continue the inquiry
Consequential intelligence requires context, authority, evidence, and accountability to become part of the operating system.
The AI Program Office sits inside a larger Musewoods inquiry about what happens when intelligence becomes capable of consequential action and institutions must make context, authority, evidence, and accountability part of the operating system.